SI2078022T1 - Spiro benzazepini, uporabljeni kot antagonisti vazopresina - Google Patents
Spiro benzazepini, uporabljeni kot antagonisti vazopresinaInfo
- Publication number
- SI2078022T1 SI2078022T1 SI200730800T SI200730800T SI2078022T1 SI 2078022 T1 SI2078022 T1 SI 2078022T1 SI 200730800 T SI200730800 T SI 200730800T SI 200730800 T SI200730800 T SI 200730800T SI 2078022 T1 SI2078022 T1 SI 2078022T1
- Authority
- SI
- Slovenia
- Prior art keywords
- renal
- hyponatremia
- hypertension
- insufficiency
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82665406P | 2006-09-22 | 2006-09-22 | |
EP07842799A EP2078022B1 (en) | 2006-09-22 | 2007-09-19 | Spiro benzazepines used as vasopressin antagonists |
PCT/US2007/078917 WO2008036755A1 (en) | 2006-09-22 | 2007-09-19 | Spiro benzazepines used as vasopressin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2078022T1 true SI2078022T1 (sl) | 2012-01-31 |
Family
ID=39030853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200730800T SI2078022T1 (sl) | 2006-09-22 | 2007-09-19 | Spiro benzazepini, uporabljeni kot antagonisti vazopresina |
Country Status (14)
Country | Link |
---|---|
US (1) | US7825110B2 (sl) |
EP (1) | EP2078022B1 (sl) |
JP (1) | JP2010504351A (sl) |
CN (1) | CN101541806A (sl) |
AT (1) | ATE532786T1 (sl) |
AU (1) | AU2007299818B2 (sl) |
CA (1) | CA2665849A1 (sl) |
CY (1) | CY1112270T1 (sl) |
DK (1) | DK2078022T3 (sl) |
ES (1) | ES2374582T3 (sl) |
PL (1) | PL2078022T3 (sl) |
PT (1) | PT2078022E (sl) |
SI (1) | SI2078022T1 (sl) |
WO (1) | WO2008036755A1 (sl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2781521A4 (en) * | 2011-10-19 | 2015-03-04 | Kowa Co | NOVEL COMPOUND OF SPIROINDOLINE AND THERAPEUTIC AGENT CONTAINING THE SAME |
US10214520B2 (en) | 2014-07-15 | 2019-02-26 | Gruenenthal Gmbh | Substituted azaspiro(4.5)decane derivatives |
TW201607923A (zh) | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環(4.5)癸烷衍生物 |
EP3321271A4 (en) | 2015-07-07 | 2020-12-16 | Japan Tobacco Inc. | PROCESS FOR THE PREPARATION OF 7H-PYRROLO [2,3-D] PYRIMIDINE DERIVATIVE AND INTERMEDIATE THEREOF |
WO2018117152A1 (ja) * | 2016-12-21 | 2018-06-28 | 日本たばこ産業株式会社 | 7H-ピロロ[2,3-d]ピリミジン誘導体の製造方法及びその合成中間体 |
CN111295373A (zh) * | 2017-09-15 | 2020-06-16 | 阿泽凡药物公司 | 用于治疗脑损伤的组合物和方法 |
US20200337590A1 (en) | 2018-01-16 | 2020-10-29 | Bayer Aktiengesellschaft | Assistance in the treatment of cardiac insufficiency |
US20240101568A1 (en) * | 2020-11-26 | 2024-03-28 | Shanghai Jemincare Pharmaceutical Co., Ltd | Novel benzazepine spiro derivative |
CN112939864B (zh) * | 2021-01-29 | 2022-05-06 | 中国医科大学 | 螺[苯并[c]氮杂-1,1’-环己基]-3-酮类化合物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4617302A (en) | 1984-10-15 | 1986-10-14 | Eli Lilly And Company | Inotropic agents |
US5985869A (en) | 1989-10-20 | 1999-11-16 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
US5258510A (en) | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
JP2905909B2 (ja) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | バソプレシン拮抗剤 |
ES2089033T3 (es) | 1989-10-20 | 1996-10-01 | Otsuka Pharma Co Ltd | Compuestos benzoheterociclicos. |
FR2686878B1 (fr) * | 1992-01-30 | 1995-06-30 | Sanofi Elf | Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant. |
US5686624A (en) | 1992-01-30 | 1997-11-11 | Sanofi | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
US5663431A (en) | 1992-01-30 | 1997-09-02 | Sanofi | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
FR2708605A1 (fr) * | 1993-07-30 | 1995-02-10 | Sanofi Sa | Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
US5849780A (en) | 1992-01-30 | 1998-12-15 | Sanofi | 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
AU5292393A (en) | 1992-10-07 | 1994-04-26 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
US5512563A (en) | 1993-07-29 | 1996-04-30 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
FR2708606B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
US5464788A (en) | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
US5753648A (en) | 1995-01-17 | 1998-05-19 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
AUPP150098A0 (en) | 1998-01-27 | 1998-02-19 | Fujisawa Pharmaceutical Co., Ltd. | Benzamide derivatives |
NZ523450A (en) | 2000-07-05 | 2004-11-26 | Ortho Mcneil Pharm Inc | Nonpeptide substituted spirobenzoazepines as vasopressin receptor antagonists |
CA2432825A1 (en) * | 2000-12-15 | 2002-06-20 | Emory University | Nonpeptide agonists and antagonists of vasopressin receptors |
US7011898B2 (en) * | 2003-03-21 | 2006-03-14 | Air Products And Chemicals, Inc. | Method of joining ITM materials using a partially or fully-transient liquid phase |
BRPI0411598A (pt) | 2003-06-17 | 2006-08-29 | Janssen Pharmaceutica Nv | espirobenzazepinas substituìdas |
AU2004252135A1 (en) | 2003-06-17 | 2005-01-06 | Janssen Pharmaceutica N.V. | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives |
CA2637838A1 (en) | 2006-01-20 | 2007-07-26 | Janssen Pharmaceutica N.V. | Novel solid forms of (4r)-1-¬4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl|-1,2,3,5-tetrahydro-spiro¬4h-1-benzazepine-4,1'-¬2|cyclopentene|-3'-carboxylic acid |
-
2007
- 2007-09-19 PT PT07842799T patent/PT2078022E/pt unknown
- 2007-09-19 DK DK07842799.4T patent/DK2078022T3/da active
- 2007-09-19 AT AT07842799T patent/ATE532786T1/de active
- 2007-09-19 PL PL07842799T patent/PL2078022T3/pl unknown
- 2007-09-19 US US11/857,891 patent/US7825110B2/en not_active Expired - Fee Related
- 2007-09-19 JP JP2009529369A patent/JP2010504351A/ja active Pending
- 2007-09-19 CA CA002665849A patent/CA2665849A1/en not_active Abandoned
- 2007-09-19 WO PCT/US2007/078917 patent/WO2008036755A1/en active Application Filing
- 2007-09-19 ES ES07842799T patent/ES2374582T3/es active Active
- 2007-09-19 CN CNA2007800432003A patent/CN101541806A/zh active Pending
- 2007-09-19 SI SI200730800T patent/SI2078022T1/sl unknown
- 2007-09-19 AU AU2007299818A patent/AU2007299818B2/en not_active Expired - Fee Related
- 2007-09-19 EP EP07842799A patent/EP2078022B1/en active Active
-
2012
- 2012-01-24 CY CY20121100081T patent/CY1112270T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL2078022T3 (pl) | 2012-04-30 |
CN101541806A (zh) | 2009-09-23 |
CY1112270T1 (el) | 2015-12-09 |
AU2007299818B2 (en) | 2012-08-02 |
EP2078022B1 (en) | 2011-11-09 |
ATE532786T1 (de) | 2011-11-15 |
PT2078022E (pt) | 2012-01-11 |
WO2008036755A1 (en) | 2008-03-27 |
JP2010504351A (ja) | 2010-02-12 |
EP2078022A1 (en) | 2009-07-15 |
CA2665849A1 (en) | 2008-03-27 |
DK2078022T3 (da) | 2012-02-13 |
US7825110B2 (en) | 2010-11-02 |
AU2007299818A1 (en) | 2008-03-27 |
ES2374582T3 (es) | 2012-02-20 |
US20080076753A1 (en) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2078022T3 (pl) | Spirobenzoazepiny stosowane jako antagoniści wazopresyny | |
MY128065A (en) | Tricyclic benzodiazepines as vasopressin receptor antagonists | |
MA33358B1 (fr) | Arylpyridine en tant qu'inhibiteurs de l'aldostérone synthase | |
CR8168A (es) | Espirobenzazepinas sustituidas | |
WO2009089537A3 (en) | Anti-cancer compounds | |
MX2012012902A (es) | Analogos heteroarilo biciclicos como moduladores de receptor acoplado a la proteina g gpr119. | |
MY147789A (en) | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors | |
TWI316057B (en) | Nonpeptide substituted spirobenzoazepines as vasopressin antagonists | |
MX352548B (es) | Compuestos disustituidos de tetrahidrofuranilo como antagonistas de receptor de bradiquinina b1. | |
MX2013004739A (es) | Derivados heterociclicos de diazenodiolato. | |
WO2006049984A3 (en) | Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists | |
ATE282621T1 (de) | Indoloazepine als vasopressin rezeptor antagonisten | |
PE20140606A1 (es) | Derivados de pirazol utiles como inhibidores de aldosterona sintasa | |
YU32702A (sh) | Nepeptidni supstituisani benzotiazepini kao antagonisti vazopresina | |
WO2007074130A3 (de) | 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1h)-on | |
MA34462B1 (fr) | Composes de thiophene 2,3,5- trisubstitues et leurs utilisations | |
PE20071234A1 (es) | Composiciones a base de bh4 para el tratamiento de la enfermedad vascular | |
JP2012526773A5 (sl) | ||
TN2013000050A1 (en) | Disubstituted tetrahydrofuranyl compounds as antagonists of the bradykinin b1 receptor |